HIV 'cure' looks 'promising,' Danish scientists contend

April 29, 2013
HIV 'Cure' looks 'Promising,' danish scientists contend
They're working on human trials designed to make it easier to attack AIDS-causing virus, according to published reports.

(HealthDay)—Danish scientists testing a novel HIV treatment in human trials contend that they're confident their strategy will result in a cure for the AIDS-causing virus, according to news reports.

The technique—already tested successfully in lab experiments—involves freeing the from DNA cells, where it collects in "," and bringing it to the surface of the cells, the Telegraph in Great Britain reported. Once the virus has surfaced, it can be permanently destroyed by a "vaccine" that primes the body's natural , the researchers said.

"I am almost certain that we will be successful in releasing the reservoirs of HIV," said Dr. Ole Sogaard, a senior researcher at the Aarhus University Hospital in Denmark, according to the news report. So far the are "promising," he said.

Human clinical trials are under way, said Sogaard, adding that early signs are "promising. I am almost certain that we will be successful in releasing the reservoirs of HIV," he said.

Fifteen patients are currently taking part in the trials, and if they are found to have successfully been cured of HIV, the "cure" will be tested on a wider scale, the Telegraph reported.

"The challenge will be getting the patients' immune system to recognize the virus and destroy it. This depends on the strength and sensitivity of individual immune systems," Sogaard said, the newspaper reported.

Sogaard said a "cure" is different than a preventative vaccine. That means continued awareness of unsafe behaviors—such as avoiding or sharing needles for intravenous drug use—is still the key to combating HIV.

If the Danish researchers are successful, it would obviously represent a huge step in the battle against HIV.

A large study of an experimental was halted recently because the shots weren't preventing infection, the U.S. National Institutes of Health said last week.

The clinical trial included about 2,500 people, mostly gay men, in 19 cities. Half of the participants were given the vaccine developed by the NIH and half received placebo shots. A safety review found that slightly more people who had received the vaccine later became infected with HIV. The reasons for this aren't clear.

While the vaccinations are being stopped, the NIH said it will continue to track the study participants' health, the Associated Press reported.

Numerous attempts to develop an HIV/AIDS vaccine have failed.

Explore further: Adaptive trial designs could accelerate HIV vaccine development

More information: To learn more about HIV, visit the U.S. National Library of Medicine.

Related Stories

Scientists probe how some HIV patients resist AIDS

October 1, 2012

(HealthDay)—Researchers who discovered an immune system mechanism that seems to provide some people with a natural defense against HIV say their finding could help efforts to develop a vaccine for HIV/AIDS.

Recommended for you

Targeting HIV in semen to shut down AIDS

August 18, 2015

There may be two new ways to fight AIDS—using a heat shock protein or a small molecule - to attack fibrils in semen associated with the human immunodeficiency virus (HIV) during the initial phases of infection, according ...

Vitamin D status related to immune response to HIV-1

June 15, 2015

Vitamin D plays an important part in the human immune response and deficiency can leave individuals less able to fight infections like HIV-1. Now an international team of researchers has found that high-dose vitamin D supplementation ...

HVTN 505 vaccine induced antibodies nonspecific for HIV

July 30, 2015

A study by researchers at the National Institute of Allergy and Infectious Diseases and Duke University helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection ...

Why HIV's cloak has a long tail

June 2, 2015

Virologists at Emory University School of Medicine, Yerkes National Primate Research Center, and Children's Healthcare of Atlanta have uncovered a critical detail explaining how HIV assembles its infectious yet stealthy clothing.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.